CryoMass Technologies Inc.
CryoMass Announces Non-Dilutive Financing Agreement
January 29, 2024 07:10 ET | Cryomass Technologies
CryoMass Announces Non-Dilutive Financing Agreement
scilogo.jpg
SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication
November 10, 2023 09:10 ET | SciSparc Ltd
SciSparc to conduct trial at Yale University in the USA, Tel Aviv Sourasky Medical Center in Israel and the Hannover Medical School in Germany TEL AVIV, Israel, Nov. 10, 2023 (GLOBE NEWSWIRE) --...
SOMAI GMP1
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
September 01, 2023 02:00 ET | SOMAÍ Pharmaceuticals
LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical cannabis product manufacturer, is pleased to...
Boston Hemp logo.jpg
Boston Hemp Inc. Releases Hemp Derived THCa Diamonds Through Nationwide Distribution
August 08, 2023 09:35 ET | Boston Hemp Inc.
BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via IBN - Boston Hemp Inc., a leading provider of premium hemp products, is proud to announce the nationwide release of its highly anticipated THCa...
ihl_logo.png
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
July 28, 2023 07:30 ET | Incannex Healthcare
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
Symple Seeds Opens Massive Fulfillment Center in South Florida to Service US Customers
July 26, 2023 15:13 ET | Symple Seeds
MIAMI, July 26, 2023 (GLOBE NEWSWIRE) -- Symple Seeds, a cannabis seed shipping and logistics company with over a decade in the industry, is opening a new fulfillment center in South Florida. Now,...
ihl_logo.png
Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea
July 18, 2023 07:40 ET | Incannex Healthcare
Highlights: Incannex has engaged Fortrea as the contract research organisation (‘CRO’) to manage the IND opening Phase 2/3 clinical trial investigating IHL-42X for treatment of OSA.The Phase 2/3...
THC-Classic-Trophies-The-Clear-2023
Clear Cannabis’ Products Win Numerous Awards at THC Championship, THC Classic, 7/10 Showdown, and Cannabis Awards Music Festival
July 11, 2023 11:15 ET | The Clear Cannabis
DENVER, July 11, 2023 (GLOBE NEWSWIRE) -- The Clear™, a legacy national cannabis brand of innovative distilled concentrate products, announced today that it has received additional industry...
ihl_logo.png
Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company’s Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA’)
July 06, 2023 08:42 ET | Incannex Healthcare
Highlights: Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial to assess the...
Somai logo.png
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland
June 12, 2023 01:00 ET | SOMAÍ Pharmaceuticals
LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered into a two-year supply agreement with a well-respected Polish distributor Cosma...